Poseida Therapeutics Inc (PSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -66,303 | -38,847 | -64,002 | -30,684 | -101,093 |
| Depreciation Amortization | -1,148 | -642 | 4,241 | 3,980 | 2,775 |
| Accounts receivable | -2,818 | 650 | -9,088 | -38,467 | -232 |
| Accounts payable and accrued liabilities | -131 | 966 | -6,748 | -5,536 | -5,859 |
| Other Working Capital | -16,814 | -5,996 | 13,715 | -17,054 | -8,728 |
| Other Operating Activity | 15,903 | 5,864 | 35,110 | 58,586 | 22,084 |
| Operating Cash Flow | $-71,311 | $-38,005 | $-26,772 | $-29,175 | $-91,053 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 40,626 | -3,631 | -199,422 | -113,792 | -79,611 |
| PPE Investments | -1,968 | -784 | -3,912 | -3,652 | -1,961 |
| Investing Cash Flow | $38,658 | $-4,415 | $-203,334 | $-117,444 | $-81,572 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 30,000 | 30,000 | 30,000 |
| Common Stock Issued | 1,680 | 1,680 | 76,609 | 76,551 | 713 |
| Other Financing Activity | -494 | -494 | -1,450 | -1,450 | -1,450 |
| Financing Cash Flow | $1,186 | $1,186 | $105,159 | $105,101 | $29,263 |
| Beginning Cash Position | 81,378 | 81,378 | 206,325 | 206,325 | 206,325 |
| End Cash Position | 49,911 | 40,144 | 81,378 | 164,807 | 62,963 |
| Net Cash Flow | $-31,467 | $-41,234 | $-124,947 | $-41,518 | $-143,362 |
| Free Cash Flow | |||||
| Operating Cash Flow | -71,311 | -38,005 | -26,772 | -29,175 | -91,053 |
| Capital Expenditure | -1,968 | -784 | -3,924 | -3,664 | -1,961 |
| Free Cash Flow | -73,279 | -38,789 | -30,696 | -32,839 | -93,014 |